. "Financial terms of the transaction were not disclosed.The acquisition makes inVentiv one of the top contract research organizations (CRO) worldwide, with clinical segment annual revenue of $900 million and more than 6,000 employees dedicated to clinical research in nearly 40 countries, including growth markets in Asia, Latin America, and central and eastern Europe." . . . .